Biliary excretion of vanadium in rats

Area of Science:

• Toxicology
• Pharmacokinetics
• Trace element metabolism

Background:

• Vanadium is a trace element with potential toxicity.
• Understanding its excretion pathways is crucial for risk assessment.

Purpose of the Study:

• To investigate the biliary excretion of pentavalent vanadium in rats.
• To determine the tissue disposition and hepatic intracellular binding of vanadium.
• To assess the impact of vanadium dose and timing on excretion and toxicity.

Main Methods:

• Bile duct cannulated rats were administered 48V-labelled pentavalent vanadium intravenously.
• Tissue disposition, hepatic distribution, and binding to plasma, bile, and liver components were analyzed.
• Urine and bile excretion, bile flow, and signs of toxicity were monitored.

Main Results:

• Less than 2% of the vanadium dose was excreted into bile within 6 hours; up to 20% was eliminated in urine.
• Higher vanadium doses (30 microgram/kg) led to decreased bile flow and signs of severe toxicity.
• Vanadium passage to the liver is concentration-gradient driven, but extensive binding limits canalicular excretion.

Conclusions:

• Biliary excretion is a minor route for vanadium elimination in rats.
• Hepatic binding significantly restricts the amount of vanadium available for biliary excretion.
• Vanadium toxicity is dose-dependent and affects bile flow.